These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7492766

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells.
    Takeuchi M, Inoue N, Strickland TW, Kubota M, Wada M, Shimizu R, Hoshi S, Kozutsumi H, Takasaki S, Kobata A.
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7819-22. PubMed ID: 2813359
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction.
    Kinoshita H, Ohishi N, Tokura S, Okazaki A.
    Arzneimittelforschung; 1992 May; 42(5):682-6. PubMed ID: 1530684
    [Abstract] [Full Text] [Related]

  • 5. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
    Widness JA, Veng-Pedersen P, Schmidt RL, Lowe LS, Kisthard JA, Peters C.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
    [Abstract] [Full Text] [Related]

  • 6. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
    Kinoshita H, Ohishi N, Kato M, Tokura S, Okazaki A.
    Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
    Yoon WH, Park SJ, Kim IC, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats.
    Kato M, Kamiyama H, Okazaki A, Kumaki K, Kato Y, Sugiyama Y.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):520-7. PubMed ID: 9353365
    [Abstract] [Full Text] [Related]

  • 12. The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin.
    Wasley LC, Timony G, Murtha P, Stoudemire J, Dorner AJ, Caro J, Krieger M, Kaufman RJ.
    Blood; 1991 Jun 15; 77(12):2624-32. PubMed ID: 2043765
    [Abstract] [Full Text] [Related]

  • 13. Immunological response to repeated administration of recombinant human erythropoietin in rats: biphasic effect on its pharmacokinetics.
    Kato M, Miura K, Kamiyama H, Okazaki A, Kumaki K, Kato Y, Sugiyama Y.
    Drug Metab Dispos; 1997 Sep 15; 25(9):1039-44. PubMed ID: 9311618
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic study of darbepoetin alfa: absorption, distribution, and excretion after a single intravenous and subcutaneous administration to rats.
    Yoshioka E, Kato K, Shindo H, Mitsuoka C, Kitajima SI, Ogata H, Misaizu T.
    Xenobiotica; 2007 Jan 15; 37(1):74-90. PubMed ID: 17178635
    [Abstract] [Full Text] [Related]

  • 15. Structures and functional roles of the sugar chains of human erythropoietins.
    Takeuchi M, Kobata A.
    Glycobiology; 1991 Sep 15; 1(4):337-46. PubMed ID: 1820196
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates.
    Fukuda MN, Sasaki H, Lopez L, Fukuda M.
    Blood; 1989 Jan 15; 73(1):84-9. PubMed ID: 2910371
    [Abstract] [Full Text] [Related]

  • 18. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D, London L, Bandach I, Segev Y.
    PLoS One; 2018 Jan 15; 13(5):e0196684. PubMed ID: 29738538
    [Abstract] [Full Text] [Related]

  • 19. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin.
    Egrie JC, Dwyer E, Browne JK, Hitz A, Lykos MA.
    Exp Hematol; 2003 Apr 15; 31(4):290-9. PubMed ID: 12691916
    [Abstract] [Full Text] [Related]

  • 20. Plasma disappearance of exogenous erythropoietin in mice under different experimental conditions.
    Lezón CE, Martínez MP, Conti MI, Bozzini CE.
    Endocrine; 1998 Jun 15; 8(3):331-3. PubMed ID: 9741839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.